Skip to main content

Harwin Peter Evan's Form 4 filing

Apogee Therapeutics, Inc. (APGE) · filed Aug 11, 2026

Accession no.
0001104659-26-094087
Filed
Aug 11, 2026, 4:30 PM ET
Trade date
Aug 7, 2026
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 2 derivative transactions. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Harwin Peter EvanCIK 0001663607Director
Fairmount Healthcare Fund II L.P.CIK 0001769651Director
Fairmount Funds Management LLCCIK 0001802528Director
Kiselak TomasCIK 0001830177Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 7, 2026Common StockMOption exerciseAcquired+31,838$17.00+$541,246330,485Indirect
Aug 7, 2026Common StockMOption exerciseAcquired+10,370$43.85+$454,724.5340,855Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 7, 2026Common StockMOption exerciseDisposed−31,838$0.00$00Direct
Aug 7, 2026Common StockMOption exerciseDisposed−10,370$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)